ArticleHuman mutation2026
Ubiquitination-Associated Ductal-Fibroblast Crosstalk Shapes Tumor Progression and Prognosis in Pancreatic Ductal Adenocarcinoma.
Article in Human mutation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy characterized by a complex tumor microenvironment. Ubiquitination regulates key oncogenic processes and microenvironmental remodeling; however, its cell type-specific activity and spatial organization within the PDAC microenvironment remain poorly understood. Materials and Methods: Single-cell RNA sequencing, spatial transcriptomics, and bulk RNA-seq datasets of PDAC were integrated for multiomics analysis. Ubiquitination activity was quantified using gene-set scoring algorithms, followed by cell-communication and spatial interaction analyses. Prognostic models were constructed using bulk cohorts, and key findings were validated through gene-silencing functional assays. Results: Ubiquitination activity was significantly increased in PDAC tissues compared with adjacent normal tissues, with ductal epithelial cells and fibroblasts showing the most prominent elevation. High ubiquitination states were associated with enhanced ductal-fibroblast interactions and distinct spatial patterns linked to invasion-associated tumor regions. Integration of ubiquitination-associated gene signatures identified a robust prognostic model, highlighting an extracellular matrix-related factor consistently overexpressed in tumors and associated with poor survival. Functional assays demonstrated that suppression of this factor inhibited proliferation, migration, invasion, and survival of pancreatic cancer cells. Conclusion: Ubiquitination organizes ductal-fibroblast crosstalk within the PDAC microenvironment and links spatial tumor ecology with disease aggressiveness and patient prognosis. Targeting ubiquitination-associated microenvironmental programs may offer new strategies for prognostic stratification and therapeutic intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.